Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Virpax Pharmaceuticals, Inc. (VRPX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
   10-K10-KS-1S-1S-1/A
Revenues  22.613.50.00.00.0
            Revenue growth  68.0%    
Cost of goods sold  0.00.00.00.00.0
Gross profit  22.613.50.00.00.0
            Gross margin  100.0%100.0%   
Selling, general and administrative   [+]11.78.12.92.61.5
Research and development  10.84.81.30.61.1
Other operating expenses  21.812.0   
EBIT   [+]-21.7-11.5-4.2-3.2-2.6
            EBIT margin  -96.0%-85.6%   
Non-recurring items  0.10.5   
Interest expense   0.10.10.10.0
Other income (expense), net  0.20.10.0  
Pre-tax income  -21.7-12.1-4.3-3.3-2.6
Income taxes  0.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%
Net income  -21.7-12.1-4.3-3.3-2.6
            Net margin  -95.8%-89.6%   
   
Basic EPS   [+]($1.85)($1.81)($1.40)($1.13)($0.93)
Diluted EPS   [+]($1.85)($1.81)($1.40)($1.13)($0.93)
   
Shares outstanding (basic)   [+]11.76.73.12.92.8
Shares outstanding (diluted)   [+]11.76.73.12.92.8
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy